C122 - Multiple Sclerosis Overview III: The Pathogenesis of Multiple Sclerosis and Mechanism of Action of Treatments for MS

Event Time: Tuesday April 24, 2018 3:30 pm to 5:30 pm
Topic(s): MS and CNS Inflammatory Disease
Director(s): Olaf Stuve MD, PhD, FAAN
Description: Improved management of multiple sclerosis (MS) would result from understanding of MS pathogenesis, risk factors, immune abnormalities, and mechanism of action of MS treatments, including understanding of complications that can result from those treatments. Faculty will discuss new understanding in MS pathogenesis and how immune interventions can alter disease pathogenesis for an improved clinical outcome, and the mechanism of action of current MS therapies, including therapies targeting B cells. This program complements C98: Multiple Sclerosis Overview I: Clinical Pearls and C109: Multiple Sclerosis Overview II: Clinical Advances, but covers independent topics.
Completion Message: Participants should be able to identify steps in MS pathogenesis, treatments used in MS management, and how approved therapies affect the immune response and potential complications resulting from those interventions.
CME Credits: 2
Core Competencies: Medical Knowledge, Patient Care

Ready to register for the 2019 AAN Annual Meeting?

Register Now

Related Courses